Medpace Holdings, Inc. Earnings

Medpace Holdings, Inc.’s revenue jumped 8.29% since last year same period to $533.32Mn in the Q3 2024. On a quarterly growth basis, Medpace Holdings, Inc. has generated 0.99% jump in its revenue since last 3-months.

Medpace Holdings, Inc.’s net profit jumped 36.77% since last year same period to $96.43Mn in the Q3 2024. On a quarterly growth basis, Medpace Holdings, Inc. has generated 9.14% jump in its net profits since last 3-months.

Medpace Holdings, Inc.’s net profit margin jumped 26.3% since last year same period to 18.08% in the Q3 2024. On a quarterly growth basis, Medpace Holdings, Inc. has generated 8.07% jump in its net profit margins since last 3-months.

Medpace Holdings, Inc.’s price-to-earnings ratio after this Q3 2024 earnings stands at 29.66.

Medpace Holdings, Inc.’s earning per share (EPS) estimates for the current quarter stand at 2.78 - a 9.45% jump from last quarter’s estimates.

Medpace Holdings, Inc.’s earning per share (EPS) estimates for the current year stand at 2.78.

Medpace Holdings, Inc.’s earning per share (EPS) jumped 35.59% since last year same period to 3.01 in the Q3 2024. This indicates that the Medpace Holdings, Inc. has generated 35.59% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Medpace Holdings, Inc.’s return on assets (ROA) stands at 0.14.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Medpace Holdings, Inc.’s return on equity (ROE) stands at 0.54.